NCT06935266View on ClinicalTrials.gov

A Study of TAK-881 With and Without Ramp-Up Dosing in Healthy Adults

PHASE1RecruitingINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

April 22, 2025

Primary Completion Date

October 21, 2025

Study Completion Date

October 21, 2025

Conditions
Healthy Volunteers
Interventions
BIOLOGICAL

TAK-881

TAK-881 SC injection.

DEVICE

SC Investigational Needle Sets

The single-use only SC needle set will be used to administer TAK-881 to the target depth below the skin surface. One needle set (single or bifurcated) will be used per infusion.

Trial Locations (1)

85283

RECRUITING

Celerion, Tempe

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY

NCT06935266 - A Study of TAK-881 With and Without Ramp-Up Dosing in Healthy Adults | Biotech Hunter | Biotech Hunter